Ebola virus vaccine (Hawaii Biotech/Soligenix/University of Hawaii)

N/A

Report date: 2024/04/16 10:50:53

Base Information

Drug NameEbola virus vaccine (Hawaii Biotech/Soligenix/University of Hawaii)
Drug Alias NameEbola subunit vaccine (Soligenix)SuVax™subunit protein vaccine of recombinantly expressed Sudan Ebola virus glycoprotein (Soligenix)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHawaii Biotech IncSoligenix IncUniversity Of Hawaii
China Registration ClassN/A

Develop Information

Active CompaniesSoligenix Inc
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A